{"name":"Appili Therapeutics Inc.","slug":"appili-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Metronidazole Tablet","genericName":"Metronidazole Tablet","slug":"metronidazole-tablet","indication":"Anaerobic bacterial infections (intra-abdominal, gynecological, respiratory)","status":"marketed"}]}],"pipeline":[{"name":"Metronidazole Tablet","genericName":"Metronidazole Tablet","slug":"metronidazole-tablet","phase":"marketed","mechanism":"Metronidazole is a nitroimidazole antibiotic that disrupts bacterial and parasitic DNA by generating reactive oxygen species after being reduced in anaerobic environments.","indications":["Anaerobic bacterial infections (intra-abdominal, gynecological, respiratory)","Parasitic infections (giardiasis, trichomoniasis, amebiasis)","Bacterial vaginosis","Clostridioides difficile infection","Helicobacter pylori infection (as part of combination therapy)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPX2oyZXpuZC1VMzBJUUZ0TTZfTjR0MnBkVDRKYU03VDJzME1fSldjYi1sZDhzYTFkSmljeENMQ1NNMG1zRnNBZURPc1NPS3hOTjJTSm5BNDBDUV83Y21GZ2ZSWG85ZXVpVnJSZmdhWXA2cUZrczNrdHJ6blphWjcxLUtDRUszRFFqMXFWVmdsc3kzYXhvVHU4LUdpeEVlQVl4bUFEdw?oc=5","date":"2025-05-29","type":"pipeline","source":"McCarthy Tétrault LLP","summary":"Appili Therapeutics announces closing of public offering of C$7M - McCarthy Tétrault LLP","headline":"Appili Therapeutics announces closing of public offering of C$7M - McCarthy Tétrault LLP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxNZEE3MnJ0WXNJNFN4WHdsYldUSDdGdHl2OTgyQVhqb05qSTgtSFl2a1lTOFpjV2p3QjNMZzYwMmFyX1FWNjJYLUNiOGFyLWNpYnRLZ3hEQVFhUDIxRFZnRGVRLWUtREJOX21XLTZDcURnajZQaG12Y2JMbkZrTWdsdGJld2llYVNQV3p4Zk1WRkhDbGZoWjUtc0k2bWc1MFFUV21rWmdHT1FzcmtxdEtTSlZSSGpOSTNkdnB4U05Qdk8zTU01bVR5a0xmWGZYVzJONUNiZWhDU25SS2l5MmNSVUxtVzVid3N4cHIwS2VDazgtNDlabXZSSnBkV3ZId0pzZzJuQ3NUTQ?oc=5","date":"2025-05-21","type":"regulatory","source":"BioSpace","summary":"Saptalis Pharmaceuticals Announces the Launch of LIKMEZ® — The First and Only US FDA-Approved Ready-to-Use Oral Suspension of Metronidazole - BioSpace","headline":"Saptalis Pharmaceuticals Announces the Launch of LIKMEZ® — The First and Only US FDA-Approved Ready-to-Use Oral Suspensi","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOMzhibWkzUWh3MGEyZ2YxUFZ4YzhTd1JpNU9EaHlYWnpzRVVjRzNFSS1ERzZWdGd2R0RxdlRtUl9CSHpJWDNwN1A1OGt4Q2JodnE5Mm53OGYtNTZmbERsRXZwRzRndklGZGZnM01rcjZ6UEx2RXVqbDYzSExhUWUyZDJPeFNsZTgwQW1YZEZzLTllS2tzWXM5a19PM0o3dHBrLTc5Xw?oc=5","date":"2024-04-09","type":"deal","source":"BetaKit","summary":"Appili Therapeutics to be acquired by Virginia-based life sciences company Aditxt - BetaKit","headline":"Appili Therapeutics to be acquired by Virginia-based life sciences company Aditxt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPX3NDSE5UU2NWUEVSZzM0dnB1eHl5S2ItSWkzTFo1VF96cVNxajlLbEswd194bF9JYWE4a296Sjc5UXJqcXZDejJjUjJIOFRvUVVGdDRPY0ZKVTlmVUpzZXNCb1VpNUpGdFA5cWV5TGM2UXVDVERtOGtOc0tLUnVvVzRNdm95OHM3?oc=5","date":"2024-04-03","type":"deal","source":"Pharmaceutical Technology","summary":"Aditxt agrees to acquire Appili Therapeutics - Pharmaceutical Technology","headline":"Aditxt agrees to acquire Appili Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOQ1VNS1VQV1ZiVk9tdU9Vc1ZuQWJGbkRLZUk4RmNZeVZUSDN1VFVFV1NkclJVMFBWTkFiaC1PMjF3Wnltb2NyVFBQM1RVNmlpLWM4WU93MWM0RDY5R1hTQ3o4RW5oQlhDeTNMWldZUGZNdW5VQjk2U3RNam00S3A1UUt5SGtnSV9JelhJMDR0dVNhNmJNdDZlbHBBdEp5QkNJRW9mbVZpR1RhbGZRaXYwOVBwUjNLd3pxQnNzM015dEZiZw?oc=5","date":"2023-09-25","type":"regulatory","source":"Reuters","summary":"Canada's Appili gets US FDA approval for oral antibiotic solution - Reuters","headline":"Canada's Appili gets US FDA approval for oral antibiotic solution","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPQkxVcU5LZXRZY3l4QmNvSTZqcW13cjRJbWFfVmFoV2xxbVdZWnNQbnBNZTJKTFZRM01NOG1XNW5DWUkyd0Z5dll5NzhvYmg5NmNNVTk3OWlvbW52VVBDSUlVQkFMeHhpUHFsc0NiblFXYzAybmh4NWYzVHhEOVlnQ0YtWklpdXE2WFozc2hFU1hLSkEwWlFUWllyYU1VUEQ1S1dB?oc=5","date":"2023-06-23","type":"pipeline","source":"Business Wire","summary":"Appili Therapeutics – Press Release Correction - Business Wire","headline":"Appili Therapeutics – Press Release Correction","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxNZGYxdkRvQVNGV3ZTVzBZNElaelNlSXF3NWJJRFlvLWhnY1VtRXlzdGs5d20xaVc3WTBFZGZNU0dYZC10UFo2bEpmdzNhNUJEU2s4T1ozVmFacnFFa05KOXJOc2VmN3dESDE5UUotT0xvTlhjaW5ydlEtWnVCY05jSzZla3M0b0xTeXBjaGs3TE41UUhhSFZkYXRKdVYyS2UwQ2ljSnJ4TnBiUTZlN2tSMXZNMVRXNjVDMi1DUkZta0U4OFRvTXVrWGZHT0hTc29lek5TRWJfWHlXWEYzNy1FNEplaDAwcEs4cG1LTWhn?oc=5","date":"2022-11-14","type":"pipeline","source":"proactiveinvestors.com","summary":"Goldstorm Metals stock surges on Eric Sprott investment plus more daily small cap movers - proactiveinvestors.com","headline":"Goldstorm Metals stock surges on Eric Sprott investment plus more daily small cap movers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTFAwVUplMF9ENG1yN2wxbmVBUmsxdWZqa0o3eUhreVhEcVlKb01NOTV4dUU0OWYzVkhmczc4Tnlqc3JINlpMcW1JenFuZnNHZ1pJOVR3amhHdUE?oc=5","date":"2020-09-18","type":"pipeline","source":"TradingView","summary":"APLI Stock Price and Chart — TSX:APLI - TradingView","headline":"APLI Stock Price and Chart — TSX:APLI","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}